Author(s): Mr. Mayur S. Jain, Dr. Shashikant D. Barhate, Mr. Bhushan P. Gayakwad

Email(s): mayurjain176@gmail.com

DOI: 10.5958/2231-5659.2018.00010.3   

Address: Mr. Mayur S. Jain1*, Dr. Shashikant D. Barhate2, Mr. Bhushan P. Gayakwad3
Shree Sureshadada Jain Institutes of Pharmaceutical Education and Research, Jammer, Maharashtra (India).
*Corresponding Author

Published In:   Volume - 8,      Issue - 1,     Year - 2018


ABSTRACT:
Probenecid is s prototypical uricosuric agent which is predominantly used to inhibit the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy. Probenecid, also sold under the brand name Probalan, is a medication that increases uric acid excretion in the urine. It is primarily used in treatment of gout and hyperuricemia. Probenecid was developed as an alternative to caronamide to competitively inhibit renal excretion of some drugs, thereby increasing their plasma concentration and prolonging their effects.


Cite this article:
Mr. Mayur S. Jain, Dr. Shashikant D. Barhate, Mr. Bhushan P. Gayakwad. Probenecid Act as an Uricosuric agent: A Review. Asian J. Res. Pharm. Sci. 2018; 8(1):45-47. doi: 10.5958/2231-5659.2018.00010.3


Recomonded Articles:

Author(s): Mr. Mayur S. Jain, Dr. Shashikant D. Barhate, Mr. Bhushan P. Gayakwad

DOI: 10.5958/2231-5659.2018.00010.3         Access: Open Access Read More

Author(s): Shivani Sharma, Hitesh K. Dhamija, Bharat Parashar

DOI:         Access: Open Access Read More

Asian Journal of Research in Pharmaceutical Sciences (AJPSci) is an international, peer-reviewed journal, devoted to pharmaceutical sciences....... Read more >>>

RNI: Not Available                     
DOI: 10.5958/2231-5659 


Recent Articles




Tags